Yadav Harlokesh Narayan, Sharma Uma Shankar, Singh Surender, Gupta Yogendra Kumar
Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India.
J Adv Pharm Technol Res. 2019 Jul-Sep;10(3):132-137. doi: 10.4103/japtr.JAPTR_386_18.
Mercury generates free radicals and subsequently increases oxidative stress, which leads to renal injury. (TT) has good anti-inflammatory and antioxidant properties. Hydroalcoholic extract of different dose of TT was evaluated against mercuric chloride-induced nephrotoxicity. Rats ( = 6) were treated with TT at doses of 100, 200, and 300 mg/kg. Drugs were administered orally for 7 days. Single dose of mercuric chloride (5 mg/kg, intraperitoneal) on the 5 day caused significant elevation of blood urea nitrogen, serum creatinine, malondialdehyde, liver fatty acid binding protein, kidney injury molecule-1, and kidney mercury level and fall in glutathione, superoxide dismutase, glutathione peroxidase, and histopathological changes in disease control as compared to normal control group ( < 0.001). Dose of TT 200 and 300 mg/kg significantly ( < 0.001) prevented the renal injury, and mercury accumulation in kidney tissues significantly decreases in higher dose, i.e., 300 mg/kg as compared to control group. Our result indicates that the treatment of TT exerted significant protection against renal damage induced by mercuric chloride possibly due to its antioxidant and anti-inflammatory properties and by decreasing the renal accumulation of mercury.
汞会产生自由基,进而增加氧化应激,导致肾损伤。(TT)具有良好的抗炎和抗氧化特性。评估了不同剂量TT的水醇提取物对氯化汞诱导的肾毒性的作用。将大鼠(n = 6)分别用100、200和300 mg/kg剂量的TT进行处理。药物口服给药7天。在第5天腹腔注射单剂量氯化汞(5 mg/kg),与正常对照组相比,疾病对照组的血尿素氮、血清肌酐、丙二醛、肝脏脂肪酸结合蛋白、肾损伤分子-1和肾脏汞含量显著升高,而谷胱甘肽、超氧化物歧化酶、谷胱甘肽过氧化物酶降低,且出现组织病理学变化(P < 0.001)。200和300 mg/kg剂量的TT能显著(P < 0.001)预防肾损伤,与对照组相比,高剂量(即300 mg/kg)时肾脏组织中的汞蓄积显著减少。我们的结果表明,TT治疗对氯化汞诱导的肾损伤具有显著的保护作用,这可能归因于其抗氧化和抗炎特性以及减少肾脏汞蓄积。